As a TCF/LEF target gene, the Axin2 is highly expressed in colon cancer due to loss of APC tumor suppressor function or β-catenin mutation [18, 19, 21], and we validated increased Axin2 abundance in colon cancer cell panels (Supplementary Figure 1A). The gene discussed is APC; the disease is neoplasm.